Submitted by Anonymous (not verified) on 9 February 2026 - 8:30
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Date of authorisation: 12/05/2016, Revision: 19, Status: Authorised